Melanoma without a detectable primary site with metastases to lymph nodes

Dermatologic Surgery

Volumn 36, Issue 6, 2010, Pages 868-876

  Rutkowski, Piotr ^a   Nowecki, Zbigniew I ^a   Dziewirski, Wirginiusz ^a   Zdzienicki, Marcin ^a   Pieñkowski, Andrzej ^a   Salamacha, MacIej ^a   Michej, Wanda ^a   Trepka, Slawomir ^b   Bylina, Elzbieta ^a   Ruka, Wlodzimierz ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b Cancer Center   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER OF UNKNOWN PRIMARY SITE; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PHYSICAL EXAMINATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952989303     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01562.x     Document Type: Article

References (24)

1. Garrison M, Nathanson L. Prognosis and staging in melanoma. Sem Oncol 1996 23 : 725 733.
2. Balch ChM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol 2001 19 : 3622 3634.
3. Balch ChM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001 19 : 3635 3648.
4. Coit DG, Rogatko A, Brennan M. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann Surg 1991 627 636.
5. Cascinelli N, Vaglini M, Nava M, et al. Prognosis of skin melanoma with regional node metastases (Stage II). J Surg Oncol 1984 25 : 240 247.
6. Hughes TM, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000 87 : 892 901.
7. Slingluff CL, Stidham KR, Ricci WM, et al. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4,682 patients. Ann Surg 1994 219 : 120 130.
8. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomised study. Mayo Clin Proc 1986 61 : 697 705.
9. Drepper H, Bieß B, Hofherr B, et al. The prognosis of patients with stage III melanoma. Cancer 1993 71 : 1239 1246.
10. Reintgen DS. Regional nodal surgery for melanoma impacts recurrence rate and survival. Ann Surg Oncol 2000 7 : 80 1.
11. Lopez R, Holyoke ED, Moore RH, Karakousis CP. Malignant melanoma with unknown primary site. J Surg Oncol 1982 19 : 151 154.
12. Chang P, Knapper WH. Metastatic melanoma of unknown primary. Cancer 1982 49 : 1106 1111. Unknown primary melanoma.
13. Anbari KK, Schuchter LM, Bucky LP, et al. Melanoma of unknown primary site: presentation, treatment, and prognosis-a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer 1997 79 : 1816 1821.
14. Morton DL, Wanek L, Nizze JA, et al. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1,134 patients from the John Wayne Cancer Clinic. Ann Surg 1991 214 : 491 499, discussion 499-501.
15. Katz KA, Jonasch E, Hodi FS, et al. Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute. Melanoma Res 2005 15 : 77 82.
16. Jonk A, Kroon BB, Rumke P, et al. Lymph node metastasis from melanoma with an unknown primary site. Br J Surg 1990 77 : 665 668.
17. Cormier JN, Xing Y, Feng L, et al. Metastatic melanoma to lymph nodes in patients with unknown primary sites. Cancer 2006 106 : 2012 2020.
18. Krug B, Crott R, Loneeux M, et al. Role of PET in the initial staging of cutaneous melanoma. Systematic review. Radiology 2008 249 : 836 844.
19. Schlagenhauff B, Stroebel W, Ellwanger U, et al. Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer 1997 80 : 60 5.
20. Lee CC, Faries MB, Wanek LA, Morton DL. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma. J Clin Oncol 2008 26 : 535 541.
21. Klausner JM, Gutman M, Inbar M, Rozin RR. Unknown primary melanoma. J Surg Oncol 1983 24 : 129 131.
22. Wong JH, Cagle LA, Morton DL. Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site. Arch Surg 1987 122 : 1380 1383.
23. DasGupta T, Bowden L, Berg JW. Malignant melanoma of unknown primary origin. Surg Gynecol Obstet 1963 117 : 341 345.
24. Nowecki Z, Rutkowski P, Michej W. The survival benefit of positive sentinel node melanoma patients after completion lymph node dissection may be limited to the subgroup of patients with primary lesion Breslow thickness greater than 1.0 and less than or equal to 4.0 mm (pT2-pT3). Ann Surg Oncol 2008 15 : 2223 2234.